Medical Properties Trust (MPT)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-09-09
$3.90-2.26%
Close 2026-09-09 · 1-day change
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-09-09
Intact: The reason to own it still holds.
Medical Properties Trust aims to reach $1 billion in annualized cash rent by end of 2026. Revenue grew 12.7% year over year in Q1 2026. The company beat earnings estimates with $0.14 EPS non-GAAP. Despite losses, management is focused on growth and improving execution.
The company is currently loss-making with negative free cash flow yield. Revenue declined from $270.3M in Q4 2025 to $252.1M in Q1 2026, showing limited progress. Analysts expect high revenue growth, but the company risks missing these targets.
The market expects about 65% revenue growth in the next year, which is aggressive given recent revenue declines. Our fair value is $11.58, reflecting a cautious view on turnaround progress. The stock trades 61% below analyst consensus price, indicating skepticism.
Breaks if: annualized cash rent falls below $900 million by end of 2026
Drive pro forma annualized cash rent from current portfolio to at least $1 billion by the end of 2026.
Stated as a priority in 4 of last 4 quarters. Revenue grew from $223.8 million in 2025-Q1 to $259.3 million in 2026-Q2, reflecting portfolio growth and rent ramp-up. Management consistently reiterated confidence in achieving at least $1 billion annualized cash rent by end 2026, indicating delivering trajectory.
“We remain confident in collecting annualized cash rent of at least $1 billion by the end of the year.”
“We remain confident in collecting annualized cash rent of at least $1 billion by the end of the year.”
“We have increased confidence that pro rata annualized cash rent from our current portfolio will exceed $1 billion by the end of 2026.”
“We remain confident in our visibility to annualized pro rata cash rent of more than $1 billion by the fourth quarter of 2026.”
Breaks if: EPS falls below $0.05 in FY26
Breaks if: FCF yield remains below -5% beyond FY27
Breaks if: YoY revenue growth falls below 0% in any quarter over next year
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story in the Real Estate sector. MPT is currently navigating through a weak financial performance and is loss-making, but it has set clear management priorities that could drive improvement over the next few years.
The market seems to have priced in a justified valuation, indicating that MPT is viewed as cheap compared to its peers. However, there is a negative expectations gap, suggesting that investors are cautious about future performance.
Management is on track with key priorities, such as achieving $1 billion in annualized cash rent and strengthening the balance sheet. However, the near-term risk of missing earnings remains elevated, as MPT has a history of consecutive earnings misses.
The future performance of MPT will depend on several factors, including whether the Fed cuts interest rates, which could benefit the Real Estate sector. Additionally, the performance of sector leaders and MPT's ability to meet its management goals will be crucial.
In the next 1 to 3 years, MPT's success will hinge on its execution of management priorities and external economic factors. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The company is facing challenges from a major debt refinance and asset sales plan. This may weaken its balance sheet strength. Recent financial performance remains weak, sitting below its industry cohort.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.